Financial Consulate’s Astera Labs ALAB Stock Holding History

Financial Consulate’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.45K	Buy	3 +1	+50%	+$265	﹤0.01%	1087
2026 Q1	$220	Buy	+2	New	+$285	﹤0.01%	1367

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Financial Consulate's ALAB Position: Q2 2026 in Review

Financial Consulate increased its Astera Labs (ALAB) stake by 50% in Q2 2026, buying an estimated $265 and bringing the position to 3 shares worth $1.45K. The position accounts for ﹤0.01% of the portfolio, ranked #1087.

Financial Consulate first reported a position in ALAB in Q1 2026 and has held it in 2 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

Financial Consulate held 3 shares of Astera Labs worth $1.45K as of Q2 2026.
Financial Consulate bought 1 Astera Labs share in Q2 2026, an estimated $265.
Astera Labs made up ﹤0.01% of Financial Consulate's portfolio in Q2 2026, its #1087 holding.
Financial Consulate first reported a position in Astera Labs in Q1 2026 and has held it in 2 quarters since.
988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Financial Consulate's 13F filing for Q2 2026, filed 23 Jul 2026.